Indications for Pleurofibrinolysis

Primary Indications

The American College of Chest Physicians recommends intrapleural fibrinolytics for complicated parapneumonic effusions with thick fluid and loculations, or empyema with overt pus, as they shorten hospital stay and reduce the need for surgical intervention 1, 2, 3
Fibrinolytics are indicated for loculations identified on ultrasound or CT imaging that prevent effective pleural fluid clearance, as recommended by the British Thoracic Society 1, 2
The presence of thick fluid with septations on imaging warrants fibrinolytic administration, even before drainage failure becomes apparent, according to the American College of Chest Physicians 1, 2
Frank pus in the pleural space is an absolute indication for fibrinolytic therapy as an adjunct to chest tube drainage and antibiotics, as recommended by the British Thoracic Society 1, 2, 3

The British Thoracic Society recommends obtaining chest ultrasound to identify septations with 81-88% sensitivity and 83-96% specificity for loculations 4
Place chest tube with ultrasound guidance at the optimal site, as recommended by the British Thoracic Society 6
Initiate appropriate antibiotics, according to the British Thoracic Society guidelines 7
If drainage is inadequate, initiate fibrinolytic therapy immediately, as recommended by the American College of Chest Physicians 1, 2

The American College of Chest Physicians recommends tPA 10 mg + DNase 5 mg twice daily for 3 days as the preferred regimen, showing superior efficacy to either agent alone 8
Urokinase 100,000 IU once daily for 3 days is the second choice, particularly in pediatric patients, as recommended by the British Thoracic Society 1, 5

Complete resolution in 85-90% of cases without surgery, as reported by the British Thoracic Society 1, 4
Shorter hospital stays, with a mean of 6.2 days with fibrinolytics vs 8.7 days with drainage alone, according to the American College of Chest Physicians 4
Greater radiological improvement, with 85% showing >40% reduction in pleural opacity, as reported by the American College of Chest Physicians 4